Worst performer this week was OPTI:Optibiotix, but AMYT:Amryt Pharma wasn't far behind, dropping 6%. Between them, these two are responsible for most of the drop in portfolio value.
Share of the Week was IKA:Ilika, rising 9% but still 24% down on my original purchase price.
Last week's optimism was short-lived, and heaven knows what's going to happen next Thursday!
| Weekly Change | |||
| Portfolio cost | £43,339.81 | +£499.98 | |
| Portfolio sell value (bid price - commission) | £43,940.68 | (+1.4%) | -£768.09 |
| Potential profits | £5,731.28 | -£351.33 | |
| Yr 2 Dividends | £486.29 | +£27.35 | |
| Yr 2 Profit from sales | £2,401.06 | +£0 | |
| Yr 2 Average monthly cash profit | £287.57 | -£4.03 | |
| Yr 2 Avg annual % of current portfolio cost | 8.0% | ||
| Total Dividends | £1,154.22 | +£27.35 | |
| Total Profit from sales | £6.241.32 | +£0 | |
| Average monthly cash profit | £333.05 | -£2.28 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 9.2% |
Portfolio cost went up because I was so fed up of my trading account being rubbish, I moved my KIBO:Kibo Mining shares out into my share account, as I'd much rather keep these long term now I have them. Value was clobbered by £768 of which about half was reduced profits and half deepened loss. A nice £27.35 dividend arrived from LOOK:Lookers, but I still don't forgive them for being 28% down and never recovering from Brexit. The dividend reduced the slip in monthly performance a tad.
Still in the black, but in great danger of going under by the end of next week.
The SIPP looks like this after week 79
| Weekly Change | |||
| Portfolio cost | £17,468.71 | +£0 | |
| Portfolio sell value (bid price - commission) | £19,277.82 | (+10.4%) | -£509.37 |
| Potential profits | £2,818.67 | -£263.53 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £1,596.81 | +£0 | |
| Yr 2 Average monthly cash profit | £49.39 | -£9.59 | |
| Yr 2 Avg annual % of current portfolio cost | 17.1% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,946.67 | +£0 | |
| Average monthly cash profit | £234.01 | -£3.00 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 16.1% |
Almost the same story as the other portfolio, with £509 drop in value, of which just over half was dropping profits and just under half deepening losses
Back to the narrow gap
The trading account looks like this after week 45
| Weekly Change | |||
| Portfolio cost | £486.05 | -£499.98 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £364.54 | (-25.0%) | +£28.73 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£2.20 | +£0.05 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | -5.4% |
Ha! Revenge is mine! That'll teach it for being so rubbish - punished by having half the value wiped out. Now it's back to the "let's see what I can do with £500" game, and KIBO:Kibo Mining is safely tucked away for the long term.
REDS:RedstoneConect is all that's left now, and that ticked up a fraction to leave the account £28 better off if you discount the removed shares.
At least it's making an interesting pattern - about the only interesting thing associated with this account!
The general election is bound to cause havoc next week, and I have a bad feeling there's going to be a horrible crash or something. Tragically I have no funds free to take advantage of any 1-day blips, so will just have to ride the storm.
Very disappointing annual results from TRX:Tissue Regenix today. Although income was up by 77% to £1.4 million, their cash burn is so massive they still posted a loss of £11 million. With only £8.2 million in cash, that's not enough to last the next year unless revenues increase significantly. There is a chance revenues will increase significantly, but I had hoped for this to have already started. I guess I'm being a bit harsh, as some of the deals to get accepted in USA were towards the end of the year and too late for the results, so I await the next trading statement eagerly. The shares dropped by 5% on the news.
I rather desperately need OPTI:Optibiotix to announce something and get back up above 80p. This is so volatile at the moment, not helped the the Yorkshire Seedcorn Fund flogging another 500,000 shares last week and not enough people buying them to save the share price. They still have 10 million left to sell, which is a bit of a worry.
I'm getting increasingly frustrated by the lack of news on free SBTX:SkinBiotherapeutics shares to OPTI:Optibiotix holders. This has been left hanging for a long time, with assertions that long term holders will be rewarded over and above day traders coming to nothing. I will sleep far better at night knowing what the plans are for this. Meanwhile, there was lots of enthusiasm after Vitafoods so an announcement of a contract next week would really help get things back into profit.
OK - deep breath and launch into election week...
No comments:
Post a Comment